Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Guinó E[au]:

Search results

Items: 1 to 50 of 55

1.

Risk of colorectal cancer in users of bisphosphonates: analysis of population-based electronic health records.

Ibáñez-Sanz G, Guinó E, Pontes C, Morros R, de la Peña-Negro LC, Quijada-Manuitt MÁ, Moreno V.

Eur J Epidemiol. 2019 Nov 16. doi: 10.1007/s10654-019-00584-5. [Epub ahead of print]

PMID:
31734885
2.

Statin use and the risk of colorectal cancer in a population-based electronic health records study.

Ibáñez-Sanz G, Guinó E, Pontes C, Quijada-Manuitt MÁ, de la Peña-Negro LC, Aragón M, Domínguez M, Rodríguez-Alonso L, Blasco A, García-Rodríguez A, Morros R, Moreno V.

Sci Rep. 2019 Sep 19;9(1):13560. doi: 10.1038/s41598-019-49877-5.

3.

Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study).

Obón-Santacana M, Romaguera D, Gracia-Lavedan E, Molinuevo A, Molina-Montes E, Shivappa N, Hebert JR, Tardón A, Castaño-Vinyals G, Moratalla F, Guinó E, Marcos-Gragera R, Azpiri M, Gil L, Olmedo-Requena R, Lozano-Lorca M, Alguacil J, Fernández-Villa T, Martín V, Molina AJ, Ederra M, Moreno-Iribas C, Perez B, Aragonés N, Castello A, Huerta JM, Dierssen-Sotos T, Gómez-Acebo I, Molina-Barceló A, Pollán M, Kogevinas M, Moreno V, Amiano P.

Nutrients. 2019 Jun 21;11(6). pii: E1406. doi: 10.3390/nu11061406.

4.

Colorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study.

Vallès X, Alonso MH, López-Caleya JF, Díez-Obrero V, Dierssen-Sotos T, Lope V, Molina-Barceló A, Chirlaque MD, Jiménez-Moleón JJ, Fernández Tardón G, Castilla J, Amiano P, Capelo R, Castaño-Vinyals G, Guinó E, Molina de la Torre AJ, Moreno-Iribas C, Pérez Gómez B, Aragonés N, Llorca J, Martín V, Kogevinas M, Pollán M, Moreno V.

Environ Int. 2018 Dec;121(Pt 1):428-434. doi: 10.1016/j.envint.2018.09.030. Epub 2018 Sep 25.

5.

New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.

Azuara D, Aussó S, Rodriguez-Moranta F, Guardiola J, Sanjuan X, Lobaton T, Boadas J, Piqueras M, Monfort D, Guinó E, Moreno V, Capellá G, de Oca J.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2555-2564. doi: 10.1093/ibd/izy255.

PMID:
30099509
6.

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.

Piulats JM, Vidal A, García-Rodríguez FJ, Muñoz C, Nadal M, Moutinho C, Martínez-Iniesta M, Mora J, Figueras A, Guinó E, Padullés L, Aytés À, Molleví DG, Puertas S, Martínez-Fernández C, Castillo W, Juliachs M, Moreno V, Muñoz P, Stefanovic M, Pujana MA, Condom E, Esteller M, Germà JR, Capella G, Farré L, Morales A, Viñals F, García-Del-Muro X, Cerón J, Villanueva A.

Clin Cancer Res. 2018 Aug 1;24(15):3755-3766. doi: 10.1158/1078-0432.CCR-17-1898. Epub 2018 Apr 4.

7.

Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Vilorio-Marqués L, Gracia E, Aragonés N, Olmedo-Requena R, Llorca J, Vidán J, Amiano P, Nos P, Fernández-Tardón G, Rada R, Chirlaque MD, Guinó E, Dávila-Batista V, Castaño-Vinyals G, Pérez-Gómez B, Mirón-Pozo B, Dierssen-Sotos T, Etxeberria J, Molinuevo A, Álvarez-Cuenllas B, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2018 Feb 1;8(1):2040. doi: 10.1038/s41598-018-20349-6.

8.

Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.

Alonso MH, Aussó S, Lopez-Doriga A, Cordero D, Guinó E, Solé X, Barenys M, de Oca J, Capella G, Salazar R, Sanz-Pamplona R, Moreno V.

Br J Cancer. 2017 Jul 25;117(3):421-431. doi: 10.1038/bjc.2017.208. Epub 2017 Jul 6.

9.

Corrigendum: Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2017 May 17;7:46807. doi: 10.1038/srep46807. No abstract available.

10.

Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2017 Feb 24;7:43263. doi: 10.1038/srep43263. Erratum in: Sci Rep. 2017 May 17;7:46807. Navarro, Pablo Fernández [corrected to Fernández-Navarro, Pablo].

11.

Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.

Rosato V, Tavani A, Gracia-Lavedan E, Guinó E, Castaño-Vinyals G, Villanueva CM, Kogevinas M, Polesel J, Serraino D, Pisa FE, Barbone F, Moreno V, La Vecchia C, Bosetti C.

Front Oncol. 2016 Oct 6;6:210. eCollection 2016.

12.

Dietary flavonoids, lignans and colorectal cancer prognosis.

Zamora-Ros R, Guinó E, Alonso MH, Vidal C, Barenys M, Soriano A, Moreno V.

Sci Rep. 2015 Sep 15;5:14148. doi: 10.1038/srep14148.

13.

Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V.

Clin Cancer Res. 2015 Oct 15;21(20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159. Epub 2015 Jun 12.

14.

Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L.

Gastroenterology. 2015 Sep;149(3):563-6. doi: 10.1053/j.gastro.2015.05.056. Epub 2015 Jun 5.

15.

Association of diabetes and diabetes treatment with incidence of breast cancer.

García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M.

Acta Diabetol. 2016 Feb;53(1):99-107. doi: 10.1007/s00592-015-0756-6. Epub 2015 Apr 29.

16.

Large differences in global transcriptional regulatory programs of normal and tumor colon cells.

Cordero D, Solé X, Crous-Bou M, Sanz-Pamplona R, Paré-Brunet L, Guinó E, Olivares D, Berenguer A, Santos C, Salazar R, Biondo S, Moreno V.

BMC Cancer. 2014 Sep 24;14:708. doi: 10.1186/1471-2407-14-708.

17.

Discovery and validation of new potential biomarkers for early detection of colon cancer.

Solé X, Crous-Bou M, Cordero D, Olivares D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca J, Salazar R, Moreno V.

PLoS One. 2014 Sep 12;9(9):e106748. doi: 10.1371/journal.pone.0106748. eCollection 2014.

18.

Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.

Closa A, Cordero D, Sanz-Pamplona R, Solé X, Crous-Bou M, Paré-Brunet L, Berenguer A, Guino E, Lopez-Doriga A, Guardiola J, Biondo S, Salazar R, Moreno V.

Carcinogenesis. 2014 Sep;35(9):2039-46. doi: 10.1093/carcin/bgu092. Epub 2014 Apr 23.

19.

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.

Sanz-Pamplona R, Berenguer A, Cordero D, Molleví DG, Crous-Bou M, Sole X, Paré-Brunet L, Guino E, Salazar R, Santos C, de Oca J, Sanjuan X, Rodriguez-Moranta F, Moreno V.

Mol Cancer. 2014 Mar 5;13:46. doi: 10.1186/1476-4598-13-46.

20.

Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.

Seguí N, Guinó E, Pineda M, Navarro M, Bellido F, Lázaro C, Blanco I, Moreno V, Capellá G, Valle L.

PLoS One. 2014 Feb 3;9(2):e86063. doi: 10.1371/journal.pone.0086063. eCollection 2014.

21.

Evaluation of PAX3 genetic variants and nevus number.

Ogbah Z, Badenas C, Harland M, Puig-Butille JA, Elliot F, Bonifaci N, Guino E, Randerson-Moor J, Chan M, Iles MM, Glass D, Brown AA, Carrera C, Kolm I, Bataille V, Spector TD, Malvehy J, Newton-Bishop J, Pujana MA, Bishop T, Puig S.

Pigment Cell Melanoma Res. 2013 Sep;26(5):666-76. doi: 10.1111/pcmr.12130. Epub 2013 Jul 4.

PMID:
23751107
22.

Telomere length and genetic anticipation in Lynch syndrome.

Seguí N, Pineda M, Guinó E, Borràs E, Navarro M, Bellido F, Moreno V, Lázaro C, Blanco I, Capellá G, Valle L.

PLoS One. 2013 Apr 23;8(4):e61286. doi: 10.1371/journal.pone.0061286. Print 2013.

23.

Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.

Ogbah Z, Visa L, Badenas C, Ríos J, Puig-Butille JA, Bonifaci N, Guino E, Augé JM, Kolm I, Carrera C, Pujana MÁ, Malvehy J, Puig S.

BMC Med Genet. 2013 Feb 16;14:26. doi: 10.1186/1471-2350-14-26.

24.

Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.

Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, Guinó E, Sanjuan X, Biondo S, Soriano A, Jurman G, Capella G, Furlanello C, Moreno V.

PLoS One. 2012;7(11):e48877. doi: 10.1371/journal.pone.0048877. Epub 2012 Nov 7. Review.

25.

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.

Santos C, López-Doriga A, Navarro M, Mateo J, Biondo S, Martínez Villacampa M, Soler G, Sanjuan X, Paules MJ, Laquente B, Guinó E, Kreisler E, Frago R, Germà JR, Moreno V, Salazar R.

Colorectal Dis. 2013 Apr;15(4):414-22. doi: 10.1111/codi.12028.

PMID:
22974322
26.

Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.

Bellido F, Guinó E, Jagmohan-Changur S, Seguí N, Pineda M, Navarro M, Lázaro C, Blanco I, Vasen HF, Moreno V, Capellá G, Wijnen JT, Valle L.

Eur J Hum Genet. 2013 May;21(5):511-6. doi: 10.1038/ejhg.2012.204. Epub 2012 Sep 5.

27.

Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study).

Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S, Salazar R, Moreno V.

Cancer Causes Control. 2013 Mar;24(3):549-57. doi: 10.1007/s10552-012-9992-z. Epub 2012 May 16.

PMID:
22588680
28.

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.

Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, Lamas MJ, López R, Candamio S, Gallardo E, Paré L, Baiget M, Páez D, López-Fernández LA, Cortejoso L, García MI, Bujanda L, González D, Gonzalo V, Rodrigo L, Reñé JM, Jover R, Brea-Fernández A, Andreu M, Bessa X, Llor X, Xicola R, Palles C, Tomlinson I, Castellví-Bel S, Castells A, Ruiz-Ponte C, Carracedo A; EPICOLON Consortium.

Pharmacogenomics J. 2013 Jun;13(3):209-17. doi: 10.1038/tpj.2012.2. Epub 2012 Feb 7.

PMID:
22310351
29.

Tools for protein-protein interaction network analysis in cancer research.

Sanz-Pamplona R, Berenguer A, Sole X, Cordero D, Crous-Bou M, Serra-Musach J, Guinó E, Pujana MÁ, Moreno V.

Clin Transl Oncol. 2012 Jan;14(1):3-14. Review.

PMID:
22262713
30.

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

Maxwell CA, Benítez J, Gómez-Baldó L, Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen H, Evans GJ, Mohan P, Català I, Petit A, Aguilar H, Villanueva A, Aytes A, Serra-Musach J, Rennert G, Lejbkowicz F, Peterlongo P, Manoukian S, Peissel B, Ripamonti CB, Bonanni B, Viel A, Allavena A, Bernard L, Radice P, Friedman E, Kaufman B, Laitman Y, Dubrovsky M, Milgrom R, Jakubowska A, Cybulski C, Gorski B, Jaworska K, Durda K, Sukiennicki G, Lubiński J, Shugart YY, Domchek SM, Letrero R, Weber BL, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, Roozendaal CE; HEBON; EMBRACE, Easton DF, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, Nevanlinna H, Heikkinen T, Couch FJ, Lindor NM, Wang X, Godwin AK, Caligo MA, Lombardi G, Loman N, Karlsson P, Ehrencrona H, Wachenfeldt Av; SWE-BRCA, Barkardottir RB, Hamann U, Rashid MU, Lasa A, Caldés T, Andrés R, Schmitt M, Assmann V, Stevens K, Offit K, Curado J, Tilgner H, Guigó R, Aiza G, Brunet J, Castellsagué J, Martrat G, Urruticoechea A, Blanco I, Tihomirova L, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB; BCFR, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Deissler H, Varon-Mateeva R, Sutter C, Niederacher D, Imyamitov E, Sinilnikova OM, Stoppa-Lyonne D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Fert Ferrer S, Collonge-Rame MA, Mortemousque I; GEMO Study Collaborators, Spurdle AB, Beesley J, Chen X, Healey S; kConFab, Barcellos-Hoff MH, Vidal M, Gruber SB, Lázaro C, Capellá G, McGuffog L, Nathanson KL, Antoniou AC, Chenevix-Trench G, Fleisch MC, Moreno V, Pujana MA.

PLoS Biol. 2011 Nov;9(11):e1001199. doi: 10.1371/journal.pbio.1001199. Epub 2011 Nov 15.

31.

Participation rates in the selection of population controls in a case-control study of colorectal cancer using two recruitment methods.

Castaño-Vinyals G, Nieuwenhuijsen MJ, Moreno V, Carrasco E, Guinó E, Kogevinas M, Villanueva CM.

Gac Sanit. 2011 Sep-Oct;25(5):353-6. doi: 10.1016/j.gaceta.2010.05.011. Epub 2011 Jun 23.

32.

No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations.

Seguí N, Stevens KN, Guinó E, Rozek LS, Moreno VR, Capellá G, Gruber SB, Valle L.

Br J Cancer. 2011 Feb 15;104(4):735-40. doi: 10.1038/sj.bjc.6606079.

33.

Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.

Landi D, Moreno V, Guino E, Vodicka P, Pardini B, Naccarati A, Canzian F, Barale R, Gemignani F, Landi S.

Mutat Res. 2011 Dec 1;717(1-2):109-15. doi: 10.1016/j.mrfmmm.2010.10.002. Epub 2010 Oct 30. Review.

PMID:
20971123
34.

Allele-specific expression of APC in adenomatous polyposis families.

Castellsagué E, González S, Guinó E, Stevens KN, Borràs E, Raymond VM, Lázaro C, Blanco I, Gruber SB, Capellá G.

Gastroenterology. 2010 Aug;139(2):439-47, 447.e1. doi: 10.1053/j.gastro.2010.04.047. Epub 2010 Apr 29.

35.

Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments.

Castellsagué E, González S, Nadal M, Campos O, Guinó E, Urioste M, Blanco I, Frebourg T, Capellá G.

Clin Chem. 2008 Jul;54(7):1132-40. doi: 10.1373/clinchem.2007.101006. Epub 2008 May 16.

36.

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.

Martinez-Balibrea E, Abad A, Aranda E, Sastre J, Manzano JL, Díaz-Rubio E, Gómez-España A, Aparicio J, García T, Maestu I, Martínez-Cardús A, Ginés A, Guino E; Spanish Group for the Treatment of Digestive Tumours.

Eur J Cancer. 2008 Jun;44(9):1229-37. doi: 10.1016/j.ejca.2008.03.025. Epub 2008 Apr 28.

PMID:
18448328
37.

Variability in prescription drug expenditures explained by adjusted clinical groups (ACG) case-mix: a cross-sectional study of patient electronic records in primary care.

Aguado A, Guinó E, Mukherjee B, Sicras A, Serrat J, Acedo M, Ferro JJ, Moreno V.

BMC Health Serv Res. 2008 Mar 4;8:53. doi: 10.1186/1472-6963-8-53.

38.

SNPassoc: an R package to perform whole genome association studies.

González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, Moreno V.

Bioinformatics. 2007 Mar 1;23(5):644-5. Epub 2007 Jan 31.

PMID:
17267436
39.

Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk.

Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, Osorio A, de Oca J, Capella G, Canzian F, Moreno V; Bellvitge Colorectal Cancer Study Group.

Eur J Cancer. 2007 Mar;43(4):762-8. Epub 2007 Jan 26.

PMID:
17258448
40.

Polymorphisms within inflammatory genes and colorectal cancer.

Landi S, Gemignani F, Bottari F, Gioia-Patricola L, Guino E, Cambray M, Biondo S, Capella G, Boldrini L, Canzian F, Moreno V.

J Negat Results Biomed. 2006 Oct 24;5:15.

41.

SNPStats: a web tool for the analysis of association studies.

Solé X, Guinó E, Valls J, Iniesta R, Moreno V.

Bioinformatics. 2006 Aug 1;22(15):1928-9. Epub 2006 May 23.

PMID:
16720584
42.

Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.

Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, González S, Guino E, Capellà G, Canzian F.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8.

43.

Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.

Dotor E, Cuatrecases M, Martínez-Iniesta M, Navarro M, Vilardell F, Guinó E, Pareja L, Figueras A, Molleví DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germà JR, Capellá G, Villanueva A.

J Clin Oncol. 2006 Apr 1;24(10):1603-11.

PMID:
16575011
44.

[Statistical analysis of genetic polymorphisms in epidemiological studies].

Iniesta R, Guinó E, Moreno V.

Gac Sanit. 2005 Jul-Aug;19(4):333-41. Spanish.

45.

Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.

Gemignani F, Landi S, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, Cambray M, Capellà G, Canzian F.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1633-8.

46.

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.

Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capellà G, Canzian F; Bellvitge Colorectal Cancer Study Group.

Pharmacogenet Genomics. 2005 Aug;15(8):535-46.

PMID:
16006997
47.

Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms.

Fernàndez V, Jares P, Beà S, Salaverria I, Guino E, de Sanjosé S, Colomer D, Ott G, Montserrat E, Campo E.

Haematologica. 2004 Nov;89(11):1322-31.

48.

Organochlorine exposure and colorectal cancer risk.

Howsam M, Grimalt JO, Guinó E, Navarro M, Martí-Ragué J, Peinado MA, Capellá G, Moreno V; Bellvitge Colorectal Cancer Group.

Environ Health Perspect. 2004 Nov;112(15):1460-6.

49.

Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer.

Moreno V, Glatt H, Guino E, Fisher E, Meinl W, Navarro M, Badosa JM, Boeing H; Bellvitge Colorectal Cancer Study Group.

Int J Cancer. 2005 Feb 10;113(4):683-6. No abstract available.

50.

Colorectal cancer risk and the APC D1822V variant.

Menéndez M, González S, Blanco I, Guinó E, Peris M, Peinado MA, Capellá G, Moreno V.

Int J Cancer. 2004 Oct 20;112(1):161-3. No abstract available.

Supplemental Content

Support Center